These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15225111)

  • 1. Anticoagulant drugs: an update.
    Kwaan HC; Samama MM
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):511-22. PubMed ID: 15225111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging anticoagulants: mechanism of action and future potential.
    Klement P; Rak J
    Vnitr Lek; 2006 Mar; 52 Suppl 1():119-22. PubMed ID: 16637459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and future antithrombotic agents in children.
    Young G
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):523-34. PubMed ID: 15225112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New trends in anticoagulant therapy.
    Pengo V; Pegoraro C; Iliceto S
    Isr Med Assoc J; 2004 Aug; 6(8):479-81. PubMed ID: 15326828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current trends in antithrombotic drug and device development.
    Fareed J
    Semin Thromb Hemost; 1996; 22 Suppl 1():3-8. PubMed ID: 8807721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New anticoagulants].
    Kawasaki T; Hirayama F
    Nihon Yakurigaku Zasshi; 2000 Nov; 116(5):275-82. PubMed ID: 11215377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in anticoagulation therapy: the role of selective inhibitors of factor Xa and thrombin in thromboprophylaxis after major orthopedic surgery.
    Andersen JC
    Semin Thromb Hemost; 2004 Dec; 30(6):609-18. PubMed ID: 15630666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New anticoagulants and their potential impact on the treatment of thromboembolic disease.
    Ansell J
    Curr Hematol Rep; 2004 Sep; 3(5):357-62. PubMed ID: 15341703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generic low-molecular-weight heparins: some practical considerations.
    Fareed J; Leong WL; Hoppensteadt DA; Jeske WP; Walenga J; Wahi R; Bick RL
    Semin Thromb Hemost; 2004 Dec; 30(6):703-13. PubMed ID: 15630677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why is factor Xa not a better target than factor IIa for therapeutic inhibition of coagulation?
    Schulman S
    Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():33-6. PubMed ID: 14730476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New anticoagulant drugs: monitoring and perioperative strategies.
    Ickx BE
    Acta Anaesthesiol Belg; 2006; 57(4):409-18. PubMed ID: 17236644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Old and new anticoagulant agents for the prevention and treatment of patients with ischemic stroke.
    Martí-Fàbregas J; Mateo J
    Cerebrovasc Dis; 2009; 27 Suppl 1():111-9. PubMed ID: 19342840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
    Savelieva I; Bajpai A; Camm AJ
    Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New anticoagulants.
    Bauer KA
    Curr Opin Hematol; 2008 Sep; 15(5):509-15. PubMed ID: 18695376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of anticoagulation.
    Hoppensteadt DA; Jeske W; Walenga J; Fareed J
    Semin Respir Crit Care Med; 2008 Feb; 29(1):90-9. PubMed ID: 18302091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ximelagatran: oral direct thrombin inhibition as anticoagulant therapy in atrial fibrillation.
    Halperin JL
    J Am Coll Cardiol; 2005 Jan; 45(1):1-9. PubMed ID: 15629364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) Pilot Trial.
    Mehta SR; Steg PG; Granger CB; Bassand JP; Faxon DP; Weitz JI; Afzal R; Rush B; Peters RJ; Natarajan MK; Velianou JL; Goodhart DM; Labinaz M; Tanguay JF; Fox KA; Yusuf S;
    Circulation; 2005 Mar; 111(11):1390-7. PubMed ID: 15781750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.